According to a recent study in Gynecologic Oncology, Hispanic women may be less likely to survive endometrial cancer than their non-Hispanic white counterparts.
According to a recent study in Gynecologic Oncology, Hispanic women may be less likely to survive endometrial cancer than their non-Hispanic white counterparts.
Researchers at the University of Texas Medical Branch at Galveston used public-use data from the Surveillance, Epidemiology, and End Results Program, which included 69,764 non-Hispanic white and Hispanic women diagnosed with endometrial cancer between 2000 and 2010. Cox proportional hazards models were used to assess potential variables: demographics, tumor characteristics, and treatment.
FDA Update: Drug labeling for pregnant and lactating women
From 2000 to 2005, US-born and foreign-born Hispanics had a higher risk of death from endometrial cancer when compared with non-Hispanic whites after full adjustment (hazard rate [HR]â =â 1.61, 95% confidence interval [CI]:1.44–1.79 and 1.27, 95% CI:1.13–1.43). However from 2006 to 2010, the risk of endometrial cancer death was not statistically significant for US-born Hispanics (HRâ =â 1.16, 95% CI:0.99–1.36), while the risk increased for foreign-born Hispanics (HRâ =â 1.31, 95% CI:1.12–1.52). Most of the survival disparities between Hispanic women and their non-Hispanic white counterparts were mediated by stage and node involvement.
Investigators concluded that Hispanic women had higher cancer-specific mortality when compared with non-Hispanic white women. During the study period of 2006 to 2010, more Hispanic women were diagnosed with endometrial uterine cancer at later stages and received fewer combination therapies. The researchers urged increased efforts to improve education on endometrial cancer and access to care for Hispanic women.
To get weekly advice for today's Ob/Gyn, subscribe to the Contemporary OB/GYN Special Delivery.
SART data indicates rise in IVF use in 2022
April 24th 2024Dive into the latest statistics from the Society for Assisted Reproductive Technology, revealing a 6% increase in in vitro fertilization cycles and a surge in egg freezing, amidst a landscape of rising fertility service demand and evolving clinical practices.
Read More
Hormone therapy safety: Study finds potential benefits for senior women
April 24th 2024A recent large-scale study challenged age-related concerns, suggesting hormone therapy may offer safety and even benefits for menopausal women aged over 65 years, aligning with The Menopause Society's 2022 Position Statement.
Read More